Clinical Trial Update: Cardiac REperfusion With Intralipid® at Reperfusion [Phase 2, Phase 3]

View source ↗

Summary

This document provides an update on a Phase 2/3 clinical trial evaluating Cardiac Reperfusion With Intralipid during reperfusion for reperfusion injury; the cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Reperfusion Injury

Drugs mentioned

• Intralipid (intravenous lipid emulsion)

Snippet

Sponsor: Nkanyiso Hadebe | Conditions: Reperfusion Injury | Phase 2, Phase 3 | Status: UNKNOWN